Skip to Content
Authors Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, Schiller D
Author Profile(s)
Journal J Surg Oncol Volume: 104 Issue: 6 Pages: 692-8
Publish Date 2011 Nov 01
PubMed ID 21713780
Abstract

Gastric cancer with peritoneal carcinomatosis has an extremely poor prognosis, which may be improved with cytoreductive surgery (CRS) combined with heated intraperitoneal chemotherapy (HIPEC). We systematically reviewed the literature regarding the efficacy of CRS + HIPEC in these patients. Electronic databases were searched from 2000 to 2010. Following CRS + HIPEC, overall median survival was 7.9 months and improved to 15 months for patients with completeness of cytoreduction scores of 0/1, however with a 30-day mortality rate of 4.8%.

webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System